Anti-tumor Effects and Mechanisms of Sesamin on Lewis Lung Cancer in C_(57)BL/6 Mice

Guoxiang Chen

2012-01-01

Abstract:Objective:To investigate the inhibitory action and mechanisms of sesamin(Ses) on Lewis lung carcinoma(3LL) in C57BL/6 mice.Methods:①In vivo experiment:We first developed in vivo the experimental models(n=40) by inoculation of 3LL tumors subcultured into the hypoderm of right oxter of C57BL/6 mice and randomly allocated them to 5 groups(n=8 for each),namely,model group[0.5% carboxymethyl cellulose 10 ml/(kg·d)],Ses administration in dose of low,medium or high[30,60,120 mg/(kg·d)],respectively) and positive controls [5-Fu 128 mg/(kg·d)].The animals were intragastrically administrated for consecutive 28 days.After that,the tumor inhibition rate and organ coefficients were calculated.Content of MMP-2 and MMP-9 in tumor tissues were detected by immunohistochemistry and TNF-α,by ELISA.HE staining was used to observer the morphological changes of the tumor tissues.②In vitro tests:MTT was used to determine the inhibition ratio of cell growth.Results:In vivo findings showed that Ses intervention in a dose of low,medium and high had slightly inhibited tumor growth in C57BL/6 mice and resulted in slow tumor proliferation,reduced tumor weight,increased spleen and thymus coefficient and down-regulated MMP-2,MMP-9 and TNF-α expression by totally dose-dependent correlation.Light microscopy revealed sparse tumor cells,patchy necrosis and nuclear pyknosis and lysis.In vitro tests by determination of the serum containing Ses also demonstrated that it had inhibited the proliferation of 3LL tumors in significant dose-dependent manner.Conclusion:Ses can in vivo and in vitro inhibit Lewis lung cancer cells in C57BL/6 mice in a certain dose-response fashion,and the potential mechanism may be associated with the role of the drug in immune function regulation and reduction of extracellular matrix degradation in animals.